Personalized Natural Killer Cell Therapy

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

• Antithymocyte Globulin (ATG) is an antibody preparation made from rabbits or horses immune cells altered with human thymocytes. ATG is used to prevent or treat acute cellular rejection after solid organ transplantation and as a therapy for certain other blood disorders.
• Busulfan is a chemotherapy cancer medication that interferes with the growth and spread of cancer cells in the body, and may be used in the treatment of many different cancers.
• Clofarabine is a chemotherapy medication that may be used in the treatment of many different cancers.
• Cyclophosphamide is a chemotherapy agent used in the treatment of cancer.
• Fludarabine is a chemotherapy medication that may be used in the treatment of many different cancers.
• Natural Killer (NK) Cells (Allogeneic) are cells already found in the body that are being modified and tested in cancer patients to try to help reduce transplant cell production time and reduce graft versus host disease. 
• Radiation therapy uses high doses of radiation to help target and kill many different kinds of cancer throughout the body.
• Rituximab is an anti-CD20 monoclonal antibody currently approved for use in B-Cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, and several autoimmune conditions.

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.